1. Home
  2. AAPG vs CNXC Comparison

AAPG vs CNXC Comparison

Compare AAPG & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • CNXC
  • Stock Information
  • Founded
  • AAPG 2009
  • CNXC 1991
  • Country
  • AAPG China
  • CNXC United States
  • Employees
  • AAPG N/A
  • CNXC N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • CNXC Computer Software: Prepackaged Software
  • Sector
  • AAPG Health Care
  • CNXC Technology
  • Exchange
  • AAPG Nasdaq
  • CNXC Nasdaq
  • Market Cap
  • AAPG 3.6B
  • CNXC 3.8B
  • IPO Year
  • AAPG 2025
  • CNXC N/A
  • Fundamental
  • Price
  • AAPG $37.20
  • CNXC $46.22
  • Analyst Decision
  • AAPG Buy
  • CNXC Buy
  • Analyst Count
  • AAPG 1
  • CNXC 4
  • Target Price
  • AAPG N/A
  • CNXC $68.75
  • AVG Volume (30 Days)
  • AAPG 8.5K
  • CNXC 676.4K
  • Earning Date
  • AAPG 08-11-2025
  • CNXC 09-24-2025
  • Dividend Yield
  • AAPG N/A
  • CNXC 2.88%
  • EPS Growth
  • AAPG N/A
  • CNXC N/A
  • EPS
  • AAPG N/A
  • CNXC 3.65
  • Revenue
  • AAPG $134,352,180.00
  • CNXC $9,625,029,000.00
  • Revenue This Year
  • AAPG N/A
  • CNXC $3.67
  • Revenue Next Year
  • AAPG $404.41
  • CNXC $2.85
  • P/E Ratio
  • AAPG N/A
  • CNXC $12.66
  • Revenue Growth
  • AAPG 341.77
  • CNXC 11.31
  • 52 Week Low
  • AAPG $16.50
  • CNXC $36.28
  • 52 Week High
  • AAPG $43.58
  • CNXC $77.00
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • CNXC 28.33
  • Support Level
  • AAPG N/A
  • CNXC $54.76
  • Resistance Level
  • AAPG N/A
  • CNXC $62.14
  • Average True Range (ATR)
  • AAPG 0.00
  • CNXC 2.22
  • MACD
  • AAPG 0.00
  • CNXC -1.27
  • Stochastic Oscillator
  • AAPG 0.00
  • CNXC 0.34

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

Share on Social Networks: